Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells

BACKGROUND: The use of glucose as the only osmotic agent in peritoneal dialysis (PD) solutions (PDSs) is believed to exert local (peritoneal) and systemic detrimental actions, particularly in diabetic PD patients. To improve peritoneal biocompatibility, we have developed more biocompatible PDSs cont...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Des Devel Ther
Hoofdauteurs: Bonomini, Mario, Di Silvestre, Sara, Di Tomo, Pamela, Di Pietro, Natalia, Mandatori, Domitilla, Di Liberato, Lorenzo, Sirolli, Vittorio, Chiarelli, Francesco, Indiveri, Cesare, Pandolfi, Assunta, Arduini, Arduino
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2016
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135076/
https://ncbi.nlm.nih.gov/pubmed/27932866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S117078
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items